CHICAGO, IL—Defibrillation testing (DFT) is not always necessary in patients receiving a subcutaneous implantable cardioverter defibrillator (S-ICD) when using a scoring system that assesses the ...
This study demonstrates the following: (1) Although DFT testing is still performed in most (71%) patients, it is not performed in 29% of patients who undergo initial ICD implantation in the United ...
For convenience, we classify these factors into four groups: (1) patient-specific factors, (2) factors related to the ICD system (leads, shock waveform, defibrillation pathway), (3) drug effects, and ...
People getting a subcutaneous implantable cardioverter-defibrillator (S-ICD) did fine skipping the defibrillation test after all, according to the PRAETORIAN-DFT randomized trial. In people randomized ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results